A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: clinical tolerance and effect on activation markers and cytokines.

Source:http://linkedlifedata.com/resource/pubmed/id/9430254

AIDS Res. Hum. Retroviruses 1997 Dec 10 13 18 1625-31

Download in:

View as

Triples

General Info

PMID
9430254